Sharon J Hutchinson
Dados Biográficos
| ID | 7446887 |
|---|---|
| NOME | Sharon J Hutchinson |
| PRENOMES | Sharon J |
| SOBRENOME | Hutchinson |
| ASSINATURA | HUTCHINSON S J |
| AFILIAÇÕES | University of Strathclyde |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 24 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 24 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2006 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2024 |
| ÍNDICE H | 0 |
Impact of the Covid-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak
Glasgow, Scotland's largest city, has been experiencing an HIV outbreak among people who inject drugs (PWID) since 2015. A key focus of the public health response has been to increase HIV testing among those at risk of infection. Our aim was to assess the impact of COVID-19 on HIV testing among PWID in Glasgow. HIV test uptake in the last 12 months was quantified among: (1) PWID recruited in six Needle Exchange Surveillance Initiative (NESI) surv…
Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland
High willingness to use drug consumption rooms among people who inject drugs in Scotland
The vast majority of PWID at greatest risk of drug-related harm in Glasgow and elsewhere in Scotland would be willing to use a DCR, supporting proposals for the introduction of DCRs nationally
Increased risk of HIV and other drug-related harms associated with injecting in public places
These findings highlight the need to address the additional harms observed among people who inject in public places and provide evidence to inform proposals in the UK and elsewhere to introduce facilities that offer safer drug consumption environments
Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Global policy and access to new hepatitis C therapies for people who inject drugs
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of a…
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Interventions to prevent HIV and Hepatitis C in people who inject drugs
Hepatitis C virus treatment for prevention among people who inject drugs
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and tolerable interferon-free direct-acting antiviral (DAA) treatments could facilitate increased uptake. We projected the potential impact of …
Injecting drug users in Scotland, 2006
Using Bayesian capture-recapture analysis, we estimated the number of current injecting drug users (IDUs) in Scotland in 2006 from the cross-counts of 5670 IDUs listed on four data-sources: social enquiry reports (901 IDUs listed), hospital records (953), drug treatment agencies (3504), and recent Hepatitis C virus (HCV) diagnoses (827 listed as IDU-risk). Further, we accessed exact numbers of opiate-related drugs-related deaths (DRDs) in 2006 an…
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland
Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow
Mortality of those who attended drug services in Scotland 1996–2006
Drug-users in Scotland are exposed to variously increased mortality risks. HCV-diagnosed individuals are particularly vulnerable, and may need additional support
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland
Meta‐analysis of drug‐related deaths soon after release from prison
Aims The transition from prison back into the community is particularly hazardous for drug‐using offenders whose tolerance for heroin has been reduced by imprisonment. Studies have indicated an increased risk of drug‐related death soon after release from prison, particularly in the first 2 weeks. For precise, up‐to‐date understanding of these risks, a meta‐analysis was conducted on the risk of drug‐related death in weeks 1 + 2 and 3 + 4 compared …
Targets for Hepatitis C virus test uptake and case-finding among injecting drug users
We re-analyse data on new diagnoses of Hepatitis C virus (HCV) for injectors in prison or attending general practices which were relied on for the cost-effectiveness of HCV testing in injectors. We use these revised estimates to suggest readily achievable targets in Scottish general practices on HCV diagnoses for injectors born in 1956–1975. Using audit data from general practices around Edinburgh, we confirm that, with effort, the suggested targ…
Missing targets on drugs-related deaths, and a Scottish paradox
Estimating the prevalence, incidence and cessation of injecting drug use in Glasgow 1960–2000
Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow
Sem obras proeminentes nesta página.
Estimating the prevalence, incidence and cessation of injecting drug use in Glasgow 1960–2000
Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow
Meta‐analysis of drug‐related deaths soon after release from prison
Aims The transition from prison back into the community is particularly hazardous for drug‐using offenders whose tolerance for heroin has been reduced by imprisonment. Studies have indicated an increased risk of drug‐related death soon after release from prison, particularly in the first 2 weeks. For precise, up‐to‐date understanding of these risks, a meta‐analysis was conducted on the risk of drug‐related death in weeks 1 + 2 and 3 + 4 compared …
Targets for Hepatitis C virus test uptake and case-finding among injecting drug users
We re-analyse data on new diagnoses of Hepatitis C virus (HCV) for injectors in prison or attending general practices which were relied on for the cost-effectiveness of HCV testing in injectors. We use these revised estimates to suggest readily achievable targets in Scottish general practices on HCV diagnoses for injectors born in 1956–1975. Using audit data from general practices around Edinburgh, we confirm that, with effort, the suggested targ…
Missing targets on drugs-related deaths, and a Scottish paradox
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland
Injecting drug users in Scotland, 2006
Using Bayesian capture-recapture analysis, we estimated the number of current injecting drug users (IDUs) in Scotland in 2006 from the cross-counts of 5670 IDUs listed on four data-sources: social enquiry reports (901 IDUs listed), hospital records (953), drug treatment agencies (3504), and recent Hepatitis C virus (HCV) diagnoses (827 listed as IDU-risk). Further, we accessed exact numbers of opiate-related drugs-related deaths (DRDs) in 2006 an…
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland
Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow
Mortality of those who attended drug services in Scotland 1996–2006
Drug-users in Scotland are exposed to variously increased mortality risks. HCV-diagnosed individuals are particularly vulnerable, and may need additional support
Hepatitis C virus treatment for prevention among people who inject drugs
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and tolerable interferon-free direct-acting antiviral (DAA) treatments could facilitate increased uptake. We projected the potential impact of …
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Interventions to prevent HIV and Hepatitis C in people who inject drugs
Global policy and access to new hepatitis C therapies for people who inject drugs
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of a…
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus
Increased risk of HIV and other drug-related harms associated with injecting in public places
These findings highlight the need to address the additional harms observed among people who inject in public places and provide evidence to inform proposals in the UK and elsewhere to introduce facilities that offer safer drug consumption environments
Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland
High willingness to use drug consumption rooms among people who inject drugs in Scotland
The vast majority of PWID at greatest risk of drug-related harm in Glasgow and elsewhere in Scotland would be willing to use a DCR, supporting proposals for the introduction of DCRs nationally
Impact of the Covid-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak
Glasgow, Scotland's largest city, has been experiencing an HIV outbreak among people who inject drugs (PWID) since 2015. A key focus of the public health response has been to increase HIV testing among those at risk of infection. Our aim was to assess the impact of COVID-19 on HIV testing among PWID in Glasgow. HIV test uptake in the last 12 months was quantified among: (1) PWID recruited in six Needle Exchange Surveillance Initiative (NESI) surv…
Medicine (22 obras) · HIV, Drug Use, Sexual Risk (17 obras) · Environmental health (14 obras) · Demography (12 obras) · Demography (11 obras) · Hepatitis C (10 obras) · Hepatitis C virus research (10 obras) · Internal Medicine (10 obras) · Virology (10 obras) · Population (9 obras)